Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis

被引：1
|
作者：
Muthiah, Mark D. [1 ,2 ]
Siddiqui, Mohammad S. [3 ]
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[3] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 04期
关键词：
D O I：
10.1111/apt.16748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [41] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [42] Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
    Lanthier, Nicolas
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (19) : 2184 - 2188
  • [43] Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
    Nicolas Lanthier
    World Journal of Hepatology, 2015, (19) : 2184 - 2188
  • [44] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [45] Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis
    Gifford, F. J.
    Dhaun, N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 564 - 566
  • [46] Hepatic stellate cell activation in non-alcoholic steatohepatitis.
    Washington, K
    Wright, K
    Hunter, E
    Raiford, DS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 169A - 169A
  • [47] Targeting cellular senescence as a therapeutic approach in non-alcoholic steatohepatitis
    Nakano, Yasuhiro
    Johmura, Yoshikazu
    ANNALS OF HEPATOLOGY, 2023, 28 (02)
  • [48] Inhibition of Mitophagy in Non-alcoholic Steatohepatitis lead to Apoptosis and Inflammation
    Sohail, Muhammad
    Kim, Seong-Jun
    Siddiqui, Aleem
    HEPATOLOGY, 2015, 62 : 684A - 685A
  • [49] Association between hepatocellular apoptosis and inflammation in patients with non-alcoholic and alcoholic steatohepatitis
    Ribeiro, PS
    Cortez-Pinto, H
    Sola, S
    Castro, RE
    Baptista, A
    Camilo, ME
    Moura, MC
    Rodrigues, CMP
    JOURNAL OF HEPATOLOGY, 2003, 38 : 199 - 199
  • [50] Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Duseja, Ajay Kumar
    De, Arka
    Mehta, Manu
    Singh, Priya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1090 - S1090
12345